INTRODUCTION
The disease in which Mutra is voided with much Dukha (difficulty) is called Mutrakrichhra.
[1] The disease in which urine is passed with difficulty is called Mutrakrichhra. The description of Mutrakrichhra is available in Atharvaveda. There are references regarding urogenital system in Atharvaveda. Urinary structures like Vrikka (kidneys), Vasti (urinary bladder), Mehana (urethra), Gavini (ureter) etc. are mentioned. Mutrakrichhra is considered as disease of Mutravaha Srotas (urinary system). So the present study has been planned to evaluate the action of Shigru [4] on E.Coli.
Acharya Charaka has described
[5]
OBJECTIVES
To evaluate the action of Shigru on E.coli and also study the complication if any occurs during the course of treatment.
Patna, having classical symptomatolgy of Mutrakricchra. Careful elucidation and evaluation of medical history of patients. The patients having classical symptomatology of Mutrakrichhra were enrolled.
Detailed physical and clinical examination on the basis of proforma specially prepared for this purpose. The patient under 70 years irrespective of caste, religion, sex, habits, Socioeconomic status and those who fulfill the diagnosis were selected for the study.
Exclusion Criteria
Patients of diabetes, hypertension. Thyroid dysfunction, Carcinoma, Sexually transmitted diseases, Pregnant womon and other severe diseases laid down as per rules are excluded.
Haematological Investigations
The following laboratory investigation were under taken in each case just before beginning of drug trial and after completion of the study. Blood -Hb%, TLC, DLC, ESR & PCV. Above mentioned all pathological investigation were done in hospital attached laboratory.
Urine routine and culture
Urine analysis for its colour, appearance, specific gravity, reaction etc. and urine culture is done to rule out microorganism.
Radiological Investigations
If required USG of urinary system (KUB) was done to rule out any pathological obstruction in urinary tract.
Study design: Single arm clinical study
Patients were subjected to medicine with the drug under trial.
Drug -Shigru Ghana Vati
Dose -500 mg BD Route of administration -oral
Duration of therapy -90 days

Diet advised
They were advised to follow the dietary restriction like;
1. High intake of water 2. Intake of plenty of fluid in the form of soups, coconut water, juices and glucose water.
3. Maintenance of perineal hygiene.
4. Not to suppress the urge of micturation.
5. Complete and frequent emptying of the bladder at short intervals.
Routine laboratory investigation and sign and symptoms scoring have been carried out before and after treatment.
The drug efficacy was assessed on the basis of clinical observation in course of the treatment, especially the sign and symptoms beside the laboratory investigation before and after the course of treatment.
Criteria for assessment 1. Cured : This was decided on the basis of following two points. Complete relief in the initial chief complaints of the patient along with the positive improvement (100% relief in signs and symptoms). Complete no growth of organism in urine culture examination.
Moderately improvement :
30-59% relief in sign and symptoms.
Mild improvement :
below -30% relief in sign and symptoms
Unchanged -No relief :
This was the group of patients in our series which did not report either symptomatic relief in their basic complain and not have negative urine examination report after treatment. For the burning micturation there was 70.51% relief with p<0.001 that was highly significant. In the frequent micturation there was 62.84% relief with p<0.001 that was highly significant. For loin pain there is 63.64% relief with p>0.05 that was insignificant. For the bodyache there was 12.5% relief with p<0.01 that was significant. The mean haemoglobin percentage decrease from 11.07gm% to 10.94gm% which was statisticlly significant (P<0.01). Initial score in the total leukocyte count was 8100 which was decreased to 7105 was significant (P<0.001). There was an decreased observed in the mean neutrophil form 63.15 to 60.46 which was significant (P>0.05). The initinal mean score of lymphocytes was 31.46 which was decreased to 28 which was statistically signifcant (P>0.05).
STATISTICAL ANALYSIS
The ESR decreased from mean score of 48.05 to 31.5 which was statistically significant (P<0.001). The mean score of S.cretanine was 1.00 which was decreased to 0.94 after treatment which was significant. The sensitivy showed that 25% patients are high sensitive for Shigru Ghana while 55% were moderate sensitive and 20% were low sensitive for Shigru Ghana. Urine Culture and Sensitivity -The observed change was 70.46 % with p<0.001 which is statistically highly significant.
DISCUSSION
The present research work has been carried out with a view to provide a scientific basis for the claims made in various Ayurvedic texts regarding the effect of Shigru Ghana. Shigru is having Katu (alkaline), Tikta in taste (Rasa). In Vipaka (post digestive effect) it is Katu and Ushna in Virya (potency) having Vata Kapha Nashaka property.
[6] It has Laghu, Ruksha, Tikshna
Guna. It is also Mutravirechaka in action.
[7]
It increases circulation of blood in kidney there by increases glomerular filtration rate and prevent Na+ (Sodium) reabsorpton in the urinary tubules which lead to increase amount of urine formation.
[8] The
Katu, Tikta Rasa are Krimighna (antimicrobial) as such it helps in treatment of E.coli. Ushna Virya has property opposite to Vata, i.e. Vasti, as such to help to cure diseses. It helps in the elimination of the bacteria out of the body due to its diuretic effect. Due to Laghu, Tikshna, Ruksha Guna it increases blood circulation in the kidney so that to eliminate bacteria. Sensitivity of Shigru shows that it has antibacterial activity.
[9]
CONCLUSION
Having analysed the result on statistical parameters, it can be concluded that Shigru is highly effective for the treatment of Mutrakrichhra (Escherichia coli). The drugs are easily available so helpful in the treatment of urinary tract infection caused by Escherichia coli. The dose and duration of Shigru can be increased to see the results in chronicity. There was no side effect observed in patients and so it is free from various drug hazards that occurs with other medicine. Shigru drug mentioned in almost all the ancient literature and has a bright future for the treatment of urinary tract infection caused by Escherichia coli.
